Leukopenia News and Research

RSS
Leukopenia is a decrease in the number of white blood cells (leukocytes) found in the blood, which places individuals at increased risk of infection.
Novartis' Tasigna capsules meets primary endpoint in comparison trial with Gleevec

Novartis' Tasigna capsules meets primary endpoint in comparison trial with Gleevec

UCB reports on the outcome of Cimzia and MTX treatment for rheumatoid arthritis

UCB reports on the outcome of Cimzia and MTX treatment for rheumatoid arthritis

Vanda Pharmaceuticals announces its agreement with Novartis Pharma AG

Vanda Pharmaceuticals announces its agreement with Novartis Pharma AG

Millennium's sNDA for VELCADE granted priority review by the FDA

Millennium's sNDA for VELCADE granted priority review by the FDA

Final results of SAPHRIS clinical study released

Final results of SAPHRIS clinical study released

Millennium's sNDA to be reviewed by the FDA

Millennium's sNDA to be reviewed by the FDA

FDA: Randomized clinical trial necessary to better interpret Clolar’s efficacy and safety in adult AML

FDA: Randomized clinical trial necessary to better interpret Clolar’s efficacy and safety in adult AML

Cimzia approved for treating adult patients with rheumatoid arthritis

Cimzia approved for treating adult patients with rheumatoid arthritis

FDA approves the usage of Valcyte for preventing CMV disease in pediatric patients

FDA approves the usage of Valcyte for preventing CMV disease in pediatric patients

Genzyme’s supplemental NDA for treating adult AML with Clolar to be discussed by the FDA

Genzyme’s supplemental NDA for treating adult AML with Clolar to be discussed by the FDA

Gene variants associated with survival advantage in African Americans with HIV

Gene variants associated with survival advantage in African Americans with HIV

Cimzia approved in U.S. for rheumatoid arthritis

Cimzia approved in U.S. for rheumatoid arthritis

Seroquel XR supplemental NDA recommended for approval

Seroquel XR supplemental NDA recommended for approval

Study of Rituxan (rituximab) in lupus nephritis misses primary endpoint

Study of Rituxan (rituximab) in lupus nephritis misses primary endpoint

Novel therapeutic approaches for various forms of thrombocytopenia

Novel therapeutic approaches for various forms of thrombocytopenia

Gleevec receives FDA priority review for gastrointestinal stromal tumors after surgery

Gleevec receives FDA priority review for gastrointestinal stromal tumors after surgery

AstraZeneca submits sNDA for SEROQUEL XR for treatment of major depressive disorder

AstraZeneca submits sNDA for SEROQUEL XR for treatment of major depressive disorder

AstraZeneca submits sNDAs for SEROQUEL XR for bipolar symptoms

AstraZeneca submits sNDAs for SEROQUEL XR for bipolar symptoms

Captopril may limit radiation kidney damage in bone marrow transplant patients

Captopril may limit radiation kidney damage in bone marrow transplant patients

Genta Incorporated announces phase 3 trial of Genasense in patients with advanced melanoma

Genta Incorporated announces phase 3 trial of Genasense in patients with advanced melanoma